Development of New Agents That Targeted Bacterial Cell Envelope Formation to Circumvent Antimicrobial Resistance
Abstract Antimicrobial resistance (AMR) of microorganisms is one of the global challenges to public health. AMR already makes a significant contribution to morbidity and mortality worldwide today and may become one of the main causes of deaths in the near future. Despite the rapid spread of AMR, antibiotics remain the priority treatment for the most dangerous bacterial infectious diseases, and a search for new antibacterial agents remains a key area of antimicrobial therapy development. In recent years, targeted approaches to drug discovery have become increasingly important. The bacterial cell wall remains a primary target for antibacterial therapy, and its targeting holds great promise for the development of new drugs. To develop new approaches to overcoming the resistance of pathogenic microorganisms, it is necessary to analyze the existing data on the mechanisms of interaction between antibiotics and thier targets. The review examines known, relevant, and promising potential targets for the creation of new antibiotics that block the formation of bacterial cell walls. The materials discussed in the review expand our understanding of the molecular biology of antibiotics and their low-molecular-weight biologically active analogs.
Authors
- Andrey Egorovich Shchekotikhin (ORCID: https://orcid.org/0000-0002-6595-0811)
- Eugenia N. Olsufyeva (ORCID: https://orcid.org/0000-0002-2598-913X)
Institutions
- Gause Institute of New Antibiotics Russian Academy of Medical Sciences (RU)
Publication Details
- Journal
- Molecular Biology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1134/s002689332660090x
- Primary Topic
- Bacterial Genetics and Biotechnology
- Type
- article
- Field-Weighted Citation Impact
- 0.00